Jul 29 (Reuters)-
OncoTherapy Science Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2016 Jun 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 0 mln 206 mln
(-99.8 pct) (-32.4 pct)
Operating loss 783 mln loss 672 mln
Recurring loss 770 mln loss 673 mln
Net loss 764 mln loss 540 mln
EPS loss 5.20 yen loss 3.67 yen
Ann Div NIL NIL
-Q2 div
-Q4 div NIL NIL
NOTE - OncoTherapy Science Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T
((Tokyo Headline News Desk +813 6441 1812))